With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...

"Where generic drugs are manufactured can make a significant difference." "The FDA assures the public that all generics patterned after the same original drug should be equivalently safe and ...

"Where generic drugs are manufactured can make a significant difference." "The FDA assures the public that all generics patterned after the same original drug should be equivalently safe and ...

Generic products are medicinal products that have the same active ingredient (active substance) as the original (branded) product and in the same quantity. However, such drugs are produced under a ...

A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...

A new study from Ohio State University has found that Indian-made generic drugs are linked to a 54% higher rate of severe ...

The Russian drugmaker Axelpharm will continue sales of its drug axitinib, which is used in kidney cancer therapy and is a generic of version of US pharma giant Pfizer’s (NYSE: PFE) Inlyta, reports The ...

Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin in India.